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Ovarian tumorAbstract Introduction: Ovarian tumors; are the second most common gynecological tumor and
are the ﬁfth commonest tumor in women. It is desirable to preoperatively differentiate benign from
malignant tumor to decide whether surgery is required, and which type of surgery is appropriate
avoiding unnecessary surgery, adding dynamic contrast and diffusion weighted to conventional
images can help in differentiation of benign ovarian tumor from malignant. DWI depends on the
fact that water molecules can diffuse freely in low cellular environment, while tissue hyper cellular-
ity causes its restriction. As a result, malignant ovarian tumors due to its hypercellular nature show
restriction of diffusion, unlike most benign tumors. This study aims at reviewing and emphasizing
the role of dynamic contrast enhanced MRI and diffusion-weighted MR in characterization of
ovarian lesions.
Patients and methods: This study was performed on 30 patients referred to the radiology depart-
ment from surgical department by ovarian masses. Pelvic MR with DWI was done for all patients,
DCE-MR was done for 29 out of 30 patients. Twenty-ﬁve patients underwent surgery with patho-
logic correlation. Five patients were put under regular follow up US for 3 months.
Results: The sensitivity of MRI was 99.9% while that of DWI was 100%. The speciﬁcity was
higher for DWI (75%) compared to conventional MRI (58.3%), as well as the accuracy which
was 73.9% for MRI while that of DWI was 86.9%. The mean ADC values for malignant lesions
were (0.84 · 103 ± 0.1 SD mm2/s), while that for benign lesions were (1.8 · 103 ± 0.5 SD mm2/s),
with cut off 1.2 · 103 and p value = 0.005. Mature teratomas showed restricted diffusion with
ADC values 0.8 · 103 mm2/s (false positive), due to mixed cellularity of the teratoma.
976 E. Nasr et al.Hemorrhagic cysts and endometriomas showed high signal not only on diffusion images but also on
corresponding ADC map and ADC values 1.3–1.4 · 103 (T2 Shine-through). Sensitivity of MRI
was 99.9% while that of DCE-MRI was 60%. The speciﬁcity was higher for DCE 91% compared
to conventional MRI sequences 58.3%, as well as the accuracy which was 73.9% for MRI while
that of DCE was 77% and so addition of DCE to the MRI is expected to increase the speciﬁcity
and the accuracy of examination.
Conclusion: Combination of DWI and DCE to conventional MRI improves the speciﬁcity of MRI
and thus increasing radiologist’s conﬁdence in image interpretation which will ﬁnally reﬂect on
patients’ outcome and prognosis.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Functional imaging is becoming increasingly important in the
evaluation of cancer patient in initial diagnosis and the assess-
ment of response to therapy. Recent technical advances allow
the use of dynamic and diffusion MR imaging in abdominal
and pelvic applications (16).
DCE-MRI depends on the leakage of contrast agent from
capillaries into the extravascular extracellular space, thus
allowing quantitative analysis which reﬂects the blood ﬂow
and the vascular permeability (1).
DCE-MRI of ovarian tumors is recommended for accurate
characterization of internal architecture, especially for delinea-
tion of necrosis, papillary projections, solid components, sep-
tations, and peritoneal implants (17).
Recent studies evaluated the use of DCE-MR imaging to
further characterize adnexal masses. It provides information
on tumor vascularity and perfusion. It also provides more post
processing quantitative data (11).
DWI is a non-invasive modality that helps in discrimina-
tion between benign and malignant lesions, increases the con-
trast between lesions and surrounding tissues, and improves
the detection and delineation of peritoneal implants at both
initial staging and follow-up. Moreover, diffusion-weighted
imaging provides quantitative information about tissue cellu-
larity that may be used to distinguish viable tumors from
treatment-related changes (7). When diffusion-weighted MR
imaging is used in gynecologic applications, cancers have
shown lower ADC (apparent diffusion coefﬁcient) values.
Increasing ADC values is noted in carcinomas responding
to radiation therapy, so it can be used as a biomarker for
treatment response, and in the evaluation of recurrence and
multi focality (10).
This study aims at reviewing and emphasizing the role of
dynamic contrast enhanced MRI and diffusion-weighted MR
in characterization of ovarian lesions.
1.1. Patients and methods
This study was performed on 30 patients presented by ovar-
ian masses, referred to the radiology department from surgi-
cal department based on U/S study as a prospective study.
Pelvic MR with DWI was done for all patients, DCE-MR
was done for 29 patients (one case was renal failure).
Twenty-ﬁve patients underwent surgery with pathologic cor-
relation. Five patients were put under regular follow up US
for 3 months.The study was conducted from November 2012 to June
2013 at the National Cancer Institute and Kasr El-Ainy
hospital.
The patient’s age ranged from 13 to 70 years.
Fourteen patients presented by vague pelvic pain, 6 were
complaining of abdominal swelling, 6 accidentally discovered
on regular post-operative follow up, 5 patients (after oopho-
rectomy) for malignant ovarian tumor and one patient (after
hemi colectomy) for cancer colon, and 4 patients were com-
plaining of vaginal bleeding and infertility (see Cases 1–4).
All cases had been subjected to the full history taking with a
special emphasis on: age, parity menstrual history, past history
of gynecological troubles or operations, Pelvi-abdominal U/S
TV/US and previous MRI.
1.2. MR imaging
MR imaging was performed on a 1.5-T MR imaging unit
(Achieva, Philips medical system). All the patients were imaged
in the supine position using pelvic phased-array Torso coil.
1.2.1. Patient preparation
Intravenous administration of an antispasmodic drug (10 mg
of visceralgine) was given immediately before MR imaging
to reduce bowel peristalsis.
2. MR imaging protocol
 Non contrast.
 Axial T1-weighted (TR/TE, 500/10 ms).
 Axial T2-weighted (TR/TE, 3300/100 ms).
 Slice thickness, 6 mm. Gap, 1 mm. FOV, 32–42 cm. Matrix,
256 · 256.
 Sagittal T2-weighted and Coronal T2-weighted, Slice
thickness, 8–10 mm. Gap, 1 mm. FOV, 40–50 cm. Matrix,
256 · 256.
 DW-MRI was acquired in the axial plane prior to adminis-
tration of contrast medium by using a single shot echo-
planar imaging sequence.
 With b values (0, 300, 600). TR/TE, 5000/70. Slice thick-
ness, 6 mm. Gap, 1 mm. FOV, and 36 cm. Matrix,
128 · 128.
Dynamic contrast-enhanced MRI: post contrast T1 fat sat
THRIVE (High Resolution Isotropic Volume Examination)
images were obtained immediately after manually injected
(a) axial spin echo T1 (TR/TE , 500/10 ms) (b) axial T2( TR/TE , 3300/100 ms )
(c) DWI echo planar (TR/TE,5000/70) (d) ADC
(e) T1 post contrast gradient echo(TR/TE,500/5)
(f) dynamic curve 
Case 1 70 year-old female patient complaining of abdominal swelling. US revealed a large left complex cystic adnexal lesion.
Conventional MRI (a & b) showed left adnexal complex cystic mass with irregular thick wall and soft tissue component, eliciting
heterogeneous low T1 and high T2 signal intensity denoting malignant looking left ovarian mass. DWI (c & d): the pelvic mass showed
restricted diffusion in the form of high signal on DWI with corresponding low signal on ADC map (arrowed). ADC value was
0.9 · 103 mm2/s. DWI suggested malignant nature. DCE-MRI (e & f): the lesion showed heterogeneous intense enhancement (arrowed)
and the curve shows the following criteria: rising curve then plateau (type 11), with early peak at 70 s, and MRE 140%. MRI diagnosis
(conventional, DWI and DCE-MRI) left complex malignant looking adnexal lesion. Pathology revealed malignant mucinous
cystadenocarcinoma.
Role of dynamic contrast enhanced MRI and DWI in characterization of ovarian masses 977gadolinium at a dose of 0.1 mmol/kg of body weight (maxi-
mum, 20 mL), this was followed by injection of 20 mL of
normal saline ﬂushing the tube. Images were obtained sequen-
tially at 0, 30, 60, 90 and 120 s. Finally, transverse, sagittal and
coronal T1-weighted gradient-echo images were acquired.2.1. MR imaging analysis
MR images were analyzed for the following: MR appearance
of the tumor; either cystic, solid or mixed, involvement of
one or both ovaries, size of the lesion, signal intensity of the
(a) axial spin echo T1 (TR/TE  500/10 ms) (b) axial T2( TR/TE , 3300/100 ms) 
(c) Axial gradient echo T2fat suppression. (d) DWI (echo planar(TR/TE,5000/70 )
(f) T1post contrast gradient echo(TR/TE,500/5)(e) ADC 
(g) dynamic curve
Case 2 27 year-old female patient complaining of infertility for 2 years. US showed left complex cystic adnexal mass lesion with soft
tissue nodule. Conventional MRI (a–c) conﬁrmed the presence of left adnexal cystic lesion with posterior wall nodule (arrow). The cyst
elicited low signal on T1 and high signal T2, the nodule showed high signal on T1 and T2 with low signal in fat suppression denoting fat
content (a benign looking left ovarian mass, likely teratoma). The lesion showed low signal on DWI (d) except the posterior nodule that
showed high signal on DWI with low signal on the corresponding ADC maps (e). ADC value of the tumor was 0.6 · 103 mm2/s. That
means restriction (malignant lesion). (f & g) The lesion showed faint wall enhancement and the curve showed the criteria of benign lesion
in the form of: slow rising curve (type 1), with no deﬁnite peak, and MRE 70%. According to conventional and DCE-MRI the lesion is a
benign looking left adnexal cystic lesion likely dermoid. Pathology revealed: mature teratoma (benign germ cell tumor).
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(a) axial spin echo T1 (TR/TE , 500/10 ms)
(c) DWI(echo planar(TR/TE,5000/70)
 (e) ADC 
(d) EADC 
(f) T1post contrast gradient echo(TR/TE,500/5).
(g) dynamic curve 
(b) axial T2( TR/TE , 3300/100 ms )
Case 3 28 year-old female patient complaining of abdominal swelling. US showed a large complex adnexal mass with thick septations
and solid component. Conventional MRI (a & b) showed a well deﬁned right adnexal lesion, dominantly cystic with thick septations
(3 mm or more) and small posterior solid component on the right side. It elicited low signal on T1, high signal on T2 (arrowed). DWI
(c–e): the tumor showed slight high signal on DWI (c), with low signal on the EADC {white arrow (e)}, and slight high signal on the
corresponding ADC maps (f), (facilitated) denoting its benignity. (ADC value of the tumor is 2.31 · 103 mm2/s). DCE-MRI (f & g): the
lesion showed faint wall and septal enhancement (arrow) and the curve showed the criteria of benign lesion in the form of: slow rising
curve (type 1), with late peak at 100 s, and MRE 85%. Diagnosis according to conventional MRI: right malignant looking, ovarian lesion,
likely serous cystadenocarcinoma. Diagnosis according to DWI and DME-MRI is benign ovarian lesion. Pathological diagnosis: struma
ovarii (benign ovarian cyst contains thyroid tissue).
Role of dynamic contrast enhanced MRI and DWI in characterization of ovarian masses 979
(a) axial spin echo T1 (TR/TE , 500/10 ms)
 (c) DWI (echo planar(TR/TE,5000/70 ) 
(e) T1post contrast gradient echo(TR/TE,500/5)
 (f)dynamic curve
(b) axial T2( TR/TE , 3300/100 ms )
(d)ADC
Case 4 50 year-old female patient complaining of vague pelvic pain. US showed complex right adnexal mass. MRI was done
conventional MRI (a & b) showed a large complex right adnexal lesion with multiple papillary projections. It elicited low signal on T1, and
high signal on T2, the projection showed slightly increased signal at T1 and reduced signal at T2 (arrow). Conventional MRI based
diagnosis is malignant looking right cystic ovarian lesion with possible hemorrhage. DWI (c & d): some areas of the lesion showed high
signal on DWI (c) with low signal on the corresponding ADC map (d) {restricted (arrowed lesion)}, suggestive of malignant lesion. ADC
value of the tumor was 1.1 · 103mm2/s. DCE-MRI (e & f): the lesion showed faint wall enhancement and the curve showed the criteria of
benign lesion in the form of: slow rising curve (type 1), with late peak at 110 s, and MRE 90%. Diagnosis according to conventional and
DWI is malignant looking right complex cystic ovarian lesion unlike the benign criteria seen at DME-MRI. Pathological diagnosis:
complicated functional cyst with hemorrhagic infarction (chronic strangulation).
980 E. Nasr et al.tumor, enhancement of the solid component if present, wall
thickness and regularity of the tumor and its enhancement,
presence of vegetation and septations, their enhancement
pattern and their size. MR images were analyzed for thepresence of ascites, presence of inﬁltrated pelvic or para aortic
lymph nodes, involvement of other pelvic organs and presence
of peritoneal and omental deposit.
Suggestive MRI signal for benign masses:
Table 1 Different histological types.
Frequency Percent Valid
percent
Histology
Valid Endometrioma 2 7.1 8.7
Mature teratoma 2 7.1 8.7
Immature teratoma 1 3.6 4.3
Struma ovarii 1 3.6 4.3
Hemorrhagic infarction
in simple cyst
1 3.6 4.3
Dysgerminoma 3 10.7 13.0
Serous cystadenoma 3 10.7 13.0
Serous cystadenocarcinoma 2 7.1 8.7
Mucinous cystadenoma 1 3.6 4.3
Mucinous cystadenocarcinoma 5 17.9 21.7
PostOp. complication(ﬁbrosis) 2 7.1 8.7
Total 23 82.1 100.0
Missing 5 17.9
Total 28 100.0
Table 2 Represents the pathological types according to MRI.
Frequency Percent
Conv. MRI mass
Valid Benign 13 46.4
Malignant 15 53.6
Total 28 100.0
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weighted images and high signal intensity on T2-weighted
images with no solid component.
 Complex benign looking masses: high signal intensity on
T1WI is considered either fat or blood. On fat suppressed
images low signal is noted with fat while high signal is still
noted in blood.
Malignant MR criteria according to (5): presence of wall
thickness >3 mm, solid vegetations more than 1 cm. Thick
septa >3 mm and areas of necrosis and breaking down. Signs
of tumor spread for staging: enlarged lymph nodes, ascites,
peritoneal and omental deposit. Post contrast images were
used for the recognition of enhancement of the solid compo-
nent, the tumor wall, septations and vegetations.
3. Interpretation of DWI
3.1. Qualitative analysis
Regarding the signal intensity: we comment if the lesion shows
low signal intensity on diffusion images with high signal in the
corresponding ADC maps (facilitated) for benign masses or
shows high signal intensity on diffusion images with lowering
of the signal in the corresponding ADC maps (restricted) for
malignant masses.
3.2. Quantitative analysis
Regarding the quantitative analysis of DWI, we generated the
ADC map, then we selected the ROI (region of interest) man-
ually on the solid and the cystic component of the tumors,
which was then automatically calculated on the work station
to get the ADC values. According to a study done by Li and
colleagues in 2011 (9), mean ADC value for benign lesions
was 1.69 · 103 ± 0.25 · 103 mm2/s, and for the malignant
was 1.03 · 103 ± 0.22 · 103 mm2/s with cut off value
1.25 · 103.
4. Interpretation of DCE-MRI
4.1. Analysis of dynamic contrast-enhanced MR images
Dynamic data were analyzed in consensus at a workstation.
The entire adnexal mass is included in the ﬁve-point dynamic
run acquisition at 0, 30, 60, 90, and 120 s after gadolinium
injection. A region of interest (ROI) is manually drawn over
the most avidly enhancing solid component, thick enhanced
wall or septations of the lesion. Signal intensity (SI)–time curve
was performed.
4.2. Quantitative dynamic contrast-enhanced MR Imaging
The maximum relative enhancement and the time peak of the
curve were reported to know if there was an early uptake
(within the ﬁrst 60 s) or not and if the maximum relative
enhancement was more than 85% (with malignant) or less.
Data were statistically described in terms of mean ± stan-
dard deviation (±SD), median and range, or frequencies
(number of cases) and percentages when appropriate.Comparison of numerical variables between the study groups
was done using Student’s t test for independent samples. For
comparing categorical data, Chi square (v2) test was per-
formed. Exact test was used instead when the expected fre-
quency is less than 5. Accuracy was represented using the
terms sensitivity, speciﬁcity, +ve predictive value, ve predic-
tive value, and overall accuracy. In addition, comparison
between groups was performed using the unpaired t test and
McNemar test. Correlations were sought using the Pearson
correlation. A p< 0.05 was considered statistically signiﬁcant.
All statistical calculations were done using computer programs
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) version 15 for Microsoft Windows Image
Evaluation.
3. Results
This study included 30 patients. The statistics included 28
cases, as 2 cases were ovarian mimics, not true ovarian masses,
one case was hydrosalpinx, and the other case was broad liga-
ment ﬁbroid. The patient’s age ranged from 13 to 70 years
(mean age 38.85 ± 17.1 SD). The age in cases with benign
tumors ranged from 25 to 62 years (mean age 36). While the
age in cases with malignant tumors; ranged from 13 to 70 years
(mean age 45). Twenty-three (23 cases) were pathologically
proved. The tumors pathologically were classiﬁed into: 12
benign and 11 malignant tumors. Benign tumors included 3
serous cystadenomas, 2 endometriomas, 2 post-operative com-
plications (in the form of seroma and ﬁbrosis), 2 mature cystic
teratomas, 1 mucinous cystadenoma, 1 struma ovarii, and 1
hemorrhagic infarction in simple cyst. Malignant tumors
Table 3 Represents results of conventional MRI compared to pathology.
Item TP FN TN FP Sensitivity Speciﬁcity (+) ve PV () ve PV Accuracy
Conv. MRI # pathology 10 1 7 5 90.91 58.33 66.67 87.50 73.91
Table 7 Represents different curve types and their percent.
Frequency Percent
Curve type
Valid Slow rising 11 39.3
Plateau 16 57.1
Total 27 96.4
Missing 1 3.6
Total 28 100.0
982 E. Nasr et al.included 5 mucinous cystadenocarcinomas, 3 dysgerminomas,
2 serous cystadenocarcinoma, and 1 immature teratoma.
Table 1 shows histological types. Missing cases that were not
pathologically proved with no surgical excision, just follow
up (hemorrhagic cysts). The tumors varied in their composi-
tion from being solid, complex cystic, mixed cystic and solid
tumors. Ten cases showed typical criteria of malignant lesions
by MRI. As size more than 6 cm, wall thickness and septae
more than 3 mm and solid vegetation more than 1 cm. Five
cases suspected to be malignant by MRI according to size,
thick septae and solid nodule were proved to be benign by
pathology (one serous cystadenoma, 1 mature teratoma, 1
struma ovarii, 1 hemorrhagic infarction in coplicex cyst,
post-operative ﬁbrosis). Cases of post operative ﬁbrosis were
seen by conventional MRI and DCE-MRI as ﬂuid collections
(blood signal) and septations with areas of restricted diffusion
but surgery was done for exploration. One case was suspected
to be benign by MRI as it did not show any septations or solid
nodule. It proved to be malignant {false negative (pathology
was mucinous cystadeno carcinoma)}. Tables 2 and 3 showed
pathological types according to MRI and results of conven-
tional MRI compared to pathology. Fourteen cases showed
restriction by DWI (high signal in diffusion images, low signal
in corresponding ADC map and low ADC values ranging
from 0.6 to 1.1 with average 0.8 · 103), 11/14 proved to be
malignant by pathology. 3/14 were false positive (2 mature ter-
atomas with ADC values 0.8 and 0.9 · 103 and chronic
infarction in functional cyst with ADC value 1.1 · 103).
Seven cases showed facilitated diffusion (low signal in diffu-
sion images, high signal on corresponding ADC map and highTable 4 Represents the pathological types according to DWI.
Frequency Percent
Diﬀusion criteria
Valid Benign 14 50.0
Malignant 14 50.0
Total 28 100.0
Table 5 Shows the comparison between the ADC values between b
ADC Mean N Std. deviatio
Benign 1.864 14 0.5852
Malignant 0.843 14 0.1651
Total 1.354 28 0.6697
Table 6 Represents results of DWI compared to pathology.
Item TP FN TN FP Sensitivi
DWI # pathology 11 0 9 3 100.ADC values range from 1.3 to 3 with average 1.8 · 103), all
these cases proved to be benign pathologically (Table 4). Five
hemorrhagic cysts (diagnosed by MRI criteria and follow up
U/S) and 2 endometriomas (proved pathologically) showed
high signal not only on diffusion images but also on corre-
sponding ADC map and ADC values 1.3–1.4 · 103 mm and
the cut off value was 1.2 · 103.
Tables 5 and 6 showed comparison of ADC values between
benign and malignant cases and results of DWI compared to
pathology.
In our study 27 cases underwent dynamic study 22/27 cases
were pathologically proved.
Six cases showed plateau curve with time of peak range
from 30 to70 s with average 53 s and MRE range from
100% to 180% with average 130% proved pathologically to
be malignant. Table 7 showed different curve types and theirenign and malignant tumors.
n Minimum Maximum Median
1.3 3.0 1.850
0.6 1.1 0.850
0.6 3.0 1.200
ty Speciﬁcity (+) ve PV () ve PV Accuracy
75.00 78.57 100 86.96
Table 8 Represents the pathological types according to
dynamic criteria.
Frequency Percent
Dynamic criteria
Valid Benign 20 71.4
Malignant 7 25.0
Total 27 96.4
Missing Missing 1 3.6
Total 28 100.0
Table 9 Shows the comparison between the MRE values between benign and malignant tumors.
MRE Mean N Std. deviation Minimum Maximum Median
Benign 73 20 22.9 40 140 70
Malignant 130 7 27 100 180 128
Total 88 27 34.9 40 180 80
Table 10 Shows the comparison between the time of peak values between benign and malignant tumors.
Time of peak Mean N Std. deviation Minimum Maximum Median
Benign 92 20 14.3 70 110 95
Malignant 53 7 14.3 30 70 60
Total 82 27 22 30 110 90
Table 11 Represents results of conventional DCE-MRI compared to pathology.
Item TP FN TN FP Sensitivity Speciﬁcity (+) ve PV () ve PV Accuracy
DCE # pathology 6 4 11 1 60 91 85 73.2 77.2
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peak range from 70 to 110 s with average 92 s, and MRE range
from 40% to 140% with average 73%. 8/11 showed slow rising
curves, 3/11 showed plateau curve. Four cases showed plateau
curve with late time of peak (80–90) seconds and low MRE
(60–75%), were suspected to be benign by the dynamic criteria.
Pathology proved the malignant nature of the lesions (3 of
them were mucinous cystadenocarcinoma, one was dysgermi-
noma). One case showed plateau curve with peak time at
60 s and MRE 110%, dynamic criteria suggested to be malig-
nant but the pathology revealed benign lesion (serous cystade-
noma (Tables 8–11).
4. Discussion
Ovarian cancer is a leading cause of death among women. It is
the second most common gynecological cancer and the ﬁfth
most common cancer in women. Unfortunately most women
are diagnosed with late stage disease, which has a poor survival
rate. Proper diagnosis of cancer can help in ﬁnding more avail-
able treatment options and in turn better prognosis (3). Proper
management depends on proper preoperative assessment, with
the help of clinical examination, laboratory tests and different
imaging modalities. Thus, helps to inform the patient about
the surgical route and the feasibility of conservative treatment
(15). Accurate characterization of an adnexal mass as being
benign can avoid unnecessary surgery especially in postmeno-
pausal women and can help young women wishing to preserve
childbearing potential to go for conservative surgery (14).
MR imaging has shown to be more speciﬁc and accurate
than US and Doppler assessment in characterizing adnexal
masses. In addition, it is the best method in delineation of local
spread to the pelvic organs. (4). DWI is one of the promising
new functional imaging techniques. As long as interpretation
of DWI is combined with the conventional MR images and
with realizing of the possible pitfalls, it has shown to be effec-
tive in the differentiation of benign from malignant adnexal
masses (15). In this study according to DWI: the sensitivityof MRI was 99.9% while that of DWI was 100%. The speci-
ﬁcity was higher for DWI (75%) compared to conventional
MRI sequences (58.3%), as well as the accuracy which was
73.9% for MRI while that of DWI was 86.9% and so addition
of DWI to the MRI is expected to increase the speciﬁcity and
the accuracy of examination. The mean ADC values for malig-
nant lesions were (0.84 · 103 ± 0.1 SD mm2/s), while that for
benign lesions were (1.8 · 103 ± 0.5 SD mm2/s), with cut off
1.2 · 103 and p value = 0.00. However p value <0.05 was
considered statistically signiﬁcant. Mature teratomas showed
restricted diffusion with ADC values 0.8 · 103 mm2/s. (false
positive), due to mixed cellularity of the teratoma. Hemor-
rhagic cysts and endometriomas showed high signal not only
on diffusion images but also on corresponding ADC map
and ADC values 1.3 to 1.4 · 103 which can be explained as
T2 Shine-through. A study was carried out by Koyama and
colleagues in 2007 (6) on 35 women to determine the accuracy
of DW imaging in the characterization of ovarian masses in
patients undergoing pelvic MRI. The study included 26 benign
tumors, 8 malignant tumors and 1 borderline tumor. Malig-
nant lesions only showed deﬁnite high signal intensity in DW
images. Addition of DWI to conventional MRI has increased
the speciﬁcity from 81% to 85%, respectively which is compa-
rable to our study where the speciﬁcity increased from 58.3%
to 75%. In their study the sensitivity of both (MRI and DWI)
was 100%. In our study, there were three false positive cases
while in their study they excluded the teratomas and hemor-
rhagic cysts. Another study was conducted by Fujii and col-
leagues in 2008 (2) on 123 ovarian lesions including 42
malignant and 81 benign lesions, most malignant ovarian
tumors as well as some of the mature cystic teratomas showed
high signal intensity on DWI. In contrast, most benign tumors
did not show abnormal high signal intensity on DWI. This
agrees with our results that all the malignant lesions (11 cases)
and two cases of mature cystic teratomas showed high signal
on DWI, this may be attributed to keratinoid substance. In
2008 (14), Thomassin-Naggara et al. evaluated the contribu-
tion of DWI in conjunction with morphological criteria to
984 E. Nasr et al.characterize 77 complex adnexal masses (30 benign and 47
malignant). In their results, low signal intensity both on
DWI and T2-weighted images in the solid component of mixed
adnexal masses may predict benignity. They concluded that the
decreased mean ADC values in benign lesions may be attrib-
uted to dense network of collagen ﬁbers within the extracellu-
lar matrix in benign ﬁbrous tumors which were included in
their study, as ﬁbromas, Brenner tumors, and cystadeno ﬁbro-
mas. In our study all the benign tumors did not show high sig-
nal on DWI except for 2 cases of mature teratomas and one
case diagnosed as chronic infarction in simple cyst. A similar
study was carried out by Takeuchi and colleagues in 2010
(13) on 47 women (33 malignant, 6 borderline, and 10 benign
tumors). Regarding the signal intensity all malignant tumors
showed high intensity on DWI, whereas only 3 cases of the
benign tumors (3 thecomas) showed high intensity. However
the presence of low intensity on T2-weighted images was sug-
gestive for benign ﬁbrous tumor. The mean (SD) ADC value in
malignant tumors (1.03 · 103 (0.19) mm2/s) was signiﬁcantly
lower than that in the 10 benign tumors 1.38 · 103
(0.30) mm2/s. Using a cutoff ADC value of 1.15, malignant
lesions had a sensitivity of 74%, speciﬁcity of 80%, PPV of
94%, and NPV of 44%. Another study was carried out by
Li and colleagues in 2011 (9) on 127 patients with pelvic
masses, (46 benign and 85 malignant). The purpose of this
study was to evaluate differences in ADC values for the solid
component of benign and malignant ovarian surface epithelial
tumors with the goal of differentiating benign versus malig-
nant ovarian tumors preoperatively. The mean ADC value
measured for the solid component signiﬁcantly differed
between the benign and malignant lesions. Mean ADC value
for benign lesions was 1.69 · 103 ± 0.25 SD mm2/s, and for
the malignant was 1.03 · 103 ± 0.22 SD mm2/s. The lower
ADC values associated with the malignant group were found
to be statistically signiﬁcant. Their results suggest that an
ADC value P1.25 · 103 mm2/s may be an optimal cutoff
value for differentiating benign and malignant ovarian tumors.
In our study, the mean ADC value for solid malignant lesions
was 0.8 · 103 ± 0.11 SD mm2/s, while that for solid benign
lesions was 1.8 · 103 ± 0.5 SD mm2/s, with
1.25 · 103 mm2/s may be a cutoff value for differentiating
benign and malignant ovarian tumors. Also in their study,
the sensitivity, speciﬁcity, PPV, NPV and accuracy of conven-
tional MR imaging all have increased from 91.8%, 78.3%,
88.6%, 83.7%, and 87.0%, respectively to 96.5%, 89.1%,
94.3%, 93.2%, and 93.1% after adding DWI to the conven-
tional MR. This was comparable to our study. Addition of
DWI to conventional raises the speciﬁcity, PPV, NPV and
accuracy from 58%, 66, 87% and 73% to 75%, 78%, 100%
and 86%.
4.1. According to DCE-MRI
In our study the sensitivity of MRI was 99.9% while that of
DCE-MRI was 60%. The speciﬁcity was higher for DCE
(91%) compared to conventional MRI sequences (58.3%), as
well as the accuracy which was 73.9% for MRI while that of
DCE was 77% and so addition of DCE to the MRI is expected
to increase the speciﬁcity and the accuracy of examination.
There was an overlap between benign and malignant lesions
according to the type of curve, as plateau curve was foundon 16/27 cases, 11 cases were malignant. According to malig-
nant lesions, time of peak ranged from 30 to 70 s with average
53 s and MRE ranged from 100% to 180% with average
130%. According to benign lesions, time of peak ranged from
70 to110 s with average 92 s, and MRE ranged from 40% to
140% with average 73%.
In 2003 (12), Sohaib and colleagues described that Malig-
nant lesions show greater enhancement than benign lesions
during the early phase of enhancement rather than the late
phase of enhancement while benign ovarian tumors showed
a gradual increase in enhancement without a well-deﬁned
peak, while, borderline ovarian tumors showed moderate ini-
tial enhancement followed by a plateau. A study done by
Livia and colleagues in 2011 (8) described that there was
some overlap in the enhancement pattern between benign
and malignant groups using all the semi-quantitative param-
eters (peak time and MRE), however most of malignant
lesions showed peak time at 60 s or less and average MRE
was 80 or more ﬁndings that is comparable to our study.
The sensitivity was 67%, speciﬁcity was 88%, matching with
our results, PPV of their study was 86% and NPV was 71%.
There were 3 false positives: a Brenner tumor, a struma ovarii
and an abscess. There were 12 false negatives. In our study
there were 4 false negative cases (3 of them were mucinous
cystadeno carcinoma, one was dysgerminoma). One false
positive case (serous cystadenoma). Another study was car-
ried out by Pegah and colleagues in 2012 (11) on 65 patients
with pelvic masses, (36 benign and 22 malignant and 7 border
line). A plateau curve, was mostly seen with borderline,
benign tumors and 11 malignant cases, the other 11 malig-
nant cases showed rapid, steep, early enhancement followed
by washout. The initial areas under the curve within the ﬁrst
60 s (IAUC-60) were signiﬁcantly higher for invasive lesions
than they were for benign and borderline masses (sensitivity,
93.7%; speciﬁcity 88%). In our study the cutoff value for
peak time was 75 s, this may be due to manual technique
of contrast injection.
5. Conclusion
Combination of DWI and DCE to conventional MRI implies:
using a completely noninvasive technique with no radiation
exposure. It improves the speciﬁcity of MRI and thus increas-
ing radiologist’s conﬁdence in image interpretation which will
ﬁnally reﬂect on patients’ outcome and prognosis. According
to DWI might be an alternative for contrast administration
especially for those were contrast intake is better avoided as
during pregnancy. Cost effective technique (no additional cost
to MRI examination), was easily added to the MR study pro-
tocols with no marked lengthening of examination time.
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